secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0001628280-25-033784
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics signs new 9-year lease for 72,846 sq ft HQ in Watertown, MA, terminates Cambridge lease
--------------------------------------------------------------------------------

- New lease at 99 Coolidge Avenue, Watertown for 72,846 sq ft; annual base rent starts at $87/sq ft with partial abatement in years 1-2.
- Rent commencement expected October 1, 2026, followed by 3% annual escalations starting October 1, 2027.
- Terminates 81,441 sq ft lease at 500 Technology Square, Cambridge (originally through Sept 2028) via Lease Termination Agreement.
- Security deposit of $2 million; two 5-year renewal options; space for HQ and R&D operations.
- Early occupancy of office portion targeted for December 15, 2025, with full delivery of build-out by December 15, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828025033784/0001628280-25-033784-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828025033784/fhtx-20250627.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-033784

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer